Meet our leadership team – who between them – have a deep knowledge of and long track records in the biotech and pharmaceutical industries.
Jonathan is a successful entrepreneur with a proven ability to develop, scale and sell companies in the medical field. He leads the board and is a present and integral member of the leadership team. After the successful growth and sale of Clinphone.
Jonathan invested in Imagen, with the ambition of working with Gareth to develop an in vitro system that could help oncologists select the right treatments for their patients.
Nicki originally qualified with PWC and has over 20 years experience as CFO for several PE backed, fast growth healthcare and technology businesses. She has taken companies from start-up to exit and has secured numerous funding rounds including equity, bank and venture debt. At Imagen she is responsible for leading financial strategy, accounting, control and compliance.
Nicki’s goal is to support Imagen’s growth and vision to accelerate drug discovery and the development of new cancer therapies to enhance patient lives.
Gareth co-founded Imagen following senior scientific roles in AstraZeneca, with the vision of developing an accurate method of modelling cancer tumour in the lab. He is an innovator in his field having developed and patented various assay development methods and is a respected expert in cell biology.
Gareth is passionate about translating science into outcomes for patients and is responsible for leading the scientific strategy and implementation at Imagen.
Dominic has over 30 years’ experience in molecular and cellular biology with roles at the European Molecular Biology Laboratory, University of Geneva and Cancer Research UK. He has successfully led drug discovery projects for CRUK from target identification through to licencing. Dominic is an enthusiastic and highly skilled scientist who was recently elected as a Fellow to the Royal Society of Biology.
Ido is a seasoned digital leader with over 10 years of experience driving digital transformation. He brings a unique blend of technical expertise in transitional science, cancer genomics and machine learning. Prior to joining Imagen, Ido was the Head of Bioinformatics at Champions Oncology, where he played a key role in driving digital growth and innovation. He has a proven track record of developing and executing digital strategies that have resulted in significant revenue growth and improved customer engagement.
Ido holds a Ms.c in Bioinformatics from Bar Ilan University and is passionate about bringing together cross-functional teams to drive digital initiatives.
Antonia is a qualified physician who worked in the NHS before transitioning to healthcare technology as Chief Medical Officer at a high-growth start-up. She brings experience building clinical teams, supporting product development, and driving process change. Antonia is passionate about delivering impact and is excited to be at the forefront of the precision medicine revolution for cancer patients.
Together with Jonathan, Neil founded Clinphone. The business went through private equity funding via Montagu/Hg to grow the business and successfully exit via float in 2006. Neil is medically qualified and is a serial pharma entrepreneur, most recently he exited Cmed Group and Exco In Touch.
He is currently NED at Greenphire, a global clinical trial payment technology business.
Rachel has broad experience across industry and academia, spanning start up biotech to large scale CRO. Prior to Imagen Therapeutics she spent 8 years at the Sanger Institute. During this time she led her department in delivering world leading, large scale projects, including deriving 100s of human iPSCs (HipSci) and cancer organoids, and ran whole genome CRIPSR screen on cancer lines, organoids and iPCS. In the government response to the COVID pandemic, she was responsible for the urgent conversion of her cell biology lab to a COVID processing facility as part of the genomic surveillance initiative.
Rachel is passionate about project, process, resource and change management, including Lean methodology. It is the application of these skills and her understanding of how to build exceptional team culture that makes her a successful leader with a proven track record of building high performing teams.